DE60043759D1 - Therapeutically useful synthetic oligonucleotides - Google Patents

Therapeutically useful synthetic oligonucleotides

Info

Publication number
DE60043759D1
DE60043759D1 DE2000643759 DE60043759A DE60043759D1 DE 60043759 D1 DE60043759 D1 DE 60043759D1 DE 2000643759 DE2000643759 DE 2000643759 DE 60043759 A DE60043759 A DE 60043759A DE 60043759 D1 DE60043759 D1 DE 60043759D1
Authority
DE
Grant status
Grant
Patent type
Prior art keywords
therapeutically useful
synthetic oligonucleotides
useful synthetic
oligonucleotides
therapeutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE2000643759
Other languages
German (de)
Inventor
Nigel C Phillips
Mario C Filion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Telesta Therapeutics Inc
Original Assignee
Telesta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55561CpG containing adjuvants; Oligonucleotide containing adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/18Type of nucleic acid acting by a non-sequence specific mechanism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3513Protein; Peptide
DE2000643759 1999-12-13 2000-12-12 Therapeutically useful synthetic oligonucleotides Active DE60043759D1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US17032599 true 1999-12-13 1999-12-13
US22892500 true 2000-08-29 2000-08-29

Publications (1)

Publication Number Publication Date
DE60043759D1 true DE60043759D1 (en) 2010-03-11

Family

ID=26865979

Family Applications (3)

Application Number Title Priority Date Filing Date
DE2000643759 Active DE60043759D1 (en) 1999-12-13 2000-12-12 Therapeutically useful synthetic oligonucleotides
DE2000636019 Active DE60036019T2 (en) 1999-12-13 2000-12-12 Synthetic oligonucleotides which are therapeutically useful
DE2000636019 Active DE60036019D1 (en) 1999-12-13 2000-12-12 Synthetic oligonucleotides which are therapeutically useful

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE2000636019 Active DE60036019T2 (en) 1999-12-13 2000-12-12 Synthetic oligonucleotides which are therapeutically useful
DE2000636019 Active DE60036019D1 (en) 1999-12-13 2000-12-12 Synthetic oligonucleotides which are therapeutically useful

Country Status (9)

Country Link
US (2) US7157436B2 (en)
EP (2) EP1867718B1 (en)
JP (1) JP4772245B2 (en)
CN (2) CN101491536B (en)
CA (1) CA2393808A1 (en)
DE (3) DE60043759D1 (en)
DK (2) DK1867718T3 (en)
ES (2) ES2288883T3 (en)
WO (1) WO2001044465A3 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030032610A1 (en) 1996-06-03 2003-02-13 Gilchrest Barbara A. Method to inhibit cell growth using oligonucleotides
US7960540B2 (en) 1999-04-08 2011-06-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US7314926B1 (en) 1999-04-08 2008-01-01 Antisoma Research Limited Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin
US8114850B2 (en) 1999-04-08 2012-02-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US6949520B1 (en) * 1999-09-27 2005-09-27 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
JP2004507469A (en) 2000-08-29 2004-03-11 バイオニケ ライフ サイエンシーズ インコーポレイテッド Adjustment of Fas and fasl expression
DE60043759D1 (en) * 1999-12-13 2010-03-11 Bioniche Life Sciences Inc Therapeutically useful synthetic oligonucleotides
WO2002069369A3 (en) * 2000-12-08 2003-06-26 Coley Pharm Gmbh Cpg-like nucleic acids and methods of use thereof
US7087586B2 (en) * 2001-04-24 2006-08-08 Bioniche Life Sciences, Inc. Oligonucleotide compositions and their use to induce differentiation of cells
CA2457783A1 (en) * 2001-08-17 2003-02-27 Bioniche Life Sciences Inc. Oligonucleotide compositions and their use to induce apoptosis
DK1432450T3 (en) * 2001-10-03 2006-05-15 Bioniche Life Sciences Inc Therapeutically useful triethyleneglycol cholesteryl-oliconucleotider
CN101160399A (en) * 2002-04-22 2008-04-09 拜奥尼茨生命科学公司 Oligonucleotide compositions and their use for the modulation of immune responses
US20040235770A1 (en) * 2003-04-02 2004-11-25 Coley Pharmaceutical Group, Ltd. Immunostimulatory nucleic acid oil-in-water formulations and related methods of use
KR20060012622A (en) * 2003-05-16 2006-02-08 하이브리돈, 인코포레이티드 Synergistic treatment of cancer using immunomers in conjuction with chemotherapeutic agents
EP1851314A2 (en) * 2005-02-24 2007-11-07 Coley Pharmaceutical Group, Inc. Immunostimulatory oligonucleotides
EP1863538A4 (en) * 2005-03-09 2009-01-14 Baylor College Medicine Direct reversal of the suppressive function of cd4+ regulatory t cells via toll-like receptor 8 signaling
EP1924279A2 (en) * 2005-09-07 2008-05-28 The Secretary of State for Defence Adjuvanted vaccine
WO2011008305A1 (en) * 2009-07-15 2011-01-20 Enzon Pharmaceuticals, Inc. Rna antagonists targeting gli2 for the treatment of leukemia
WO2010093906A3 (en) * 2009-02-12 2011-04-07 Curna, Inc. Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
GB0906234D0 (en) 2009-04-14 2009-05-20 Secr Defence Vaccine
KR100998365B1 (en) 2009-06-29 2010-12-06 압타바이오 주식회사 Novel guanosine rich modified oligonucleotides and antiproliferative activity thereof
US20150045248A1 (en) * 2012-02-28 2015-02-12 National University Corporation Tokyo University Of Agriculture And Technology Method for identifying disease associated with abundance of tdp-43 in cell

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) * 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
US4152423A (en) * 1971-11-19 1979-05-01 Agence Nationale De Valorisation De La Recherche (Anvar) Immunological agents
FR2160326B1 (en) * 1971-11-19 1975-02-07 Anvar
CA1020460A (en) * 1973-02-23 1977-11-08 Wellcome Foundation Limited (The) Isolation of immunostimulating glycopeptide from bacteria
US3976544A (en) * 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
FR2374042B1 (en) * 1976-06-04 1980-04-30 Merieux Inst
JPS6241214B2 (en) * 1978-03-10 1987-09-02 Mitsui Toatsu Chemicals
DE3011461C2 (en) * 1980-03-25 1986-10-30 Dr. Madaus & Co, 5000 Koeln, De
US4520019A (en) * 1982-04-29 1985-05-28 Ribi Immunochem Research, Inc. Stable composition and preparation thereof
US4579941A (en) * 1982-08-13 1986-04-01 Mitsuitoatsu Chemicals, Inc. Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent
US4663306A (en) * 1983-09-23 1987-05-05 Ribi Immunochem Research, Inc. Pyridine-soluble extract-refined detoxified endotoxin composition and use
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
DE3423234A1 (en) * 1984-06-23 1986-02-06 Boehringer Ingelheim Int Synergistic mixtures of interferons and tumor necrosis factor
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
DE3723075A1 (en) * 1987-07-11 1989-01-19 Boehringer Mannheim Gmbh Eukaryotic expression vectors with multimeric enhancer subelements, process for their production and use
US4958013A (en) * 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
WO1998017320A1 (en) * 1991-07-03 1998-04-30 Hyal Pharmaceutical Corporation Use of hyaluronan in gene therapy
WO1992007095A1 (en) * 1990-10-15 1992-04-30 Stratagene Arbitrarily primed polymerase chain reaction method for fingerprinting genomes
WO1992014842A1 (en) * 1991-02-21 1992-09-03 Gilead Sciences, Inc. Aptamers specific for thrombin and methods of use
US5582981A (en) * 1991-08-14 1996-12-10 Gilead Sciences, Inc. Method for identifying an oligonucleotide aptamer specific for a target
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5523389A (en) 1992-09-29 1996-06-04 Isis Pharmaceuticals, Inc. Inhibitors of human immunodeficiency virus
CN1102855C (en) * 1993-01-29 2003-03-12 维特里制药有限公司 Immunotherapeutic composition
US5567604A (en) * 1993-04-23 1996-10-22 Aronex Pharmaceuticals, Inc. Anti-viral guanosine-rich oligonucleotides
CN1164869A (en) * 1994-08-30 1997-11-12 联邦科学和工业研究组织 Plant transcription regulators from circovirus
US5643890A (en) 1995-01-31 1997-07-01 The Board Of Regents Of The University Of Nebraska Synthetic oligonucleotides which mimic telomeric sequences for use in treatment of cancer and other diseases
CN1181016A (en) * 1995-02-14 1998-05-06 博奥尼彻公司 Use of hyaluronic acid for the treatment of interstitial cystitis
CN1154702A (en) 1995-05-19 1997-07-16 海布里登公司 Oligonucleotides with anti-cytomegalovirus activity
ES2196157T3 (en) * 1995-06-06 2003-12-16 Hybridon Inc Oligonucleotides specific for the Hepatitis C virus.
US5990299A (en) 1995-08-14 1999-11-23 Icn Pharmaceuticals, Inc. Control of CD44 gene expression for therapeutic use
CA2236825A1 (en) 1995-11-21 1997-05-29 Icn Pharmaceuticals, Inc. Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor
WO1997020924A1 (en) * 1995-12-04 1997-06-12 Saicom S.R.L A class of oligonucleotides, therapeutically useful as antitumoural agents
US6015710A (en) * 1996-04-09 2000-01-18 The University Of Texas System Modulation of mammalian telomerase by peptide nucleic acids
EP1011729B1 (en) * 1996-05-20 2008-01-09 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Oligonucleotides which specifically bind retroviral nucleocapsid proteins
DK1003525T3 (en) * 1997-08-05 2003-03-24 Bioniche Life Sciences Inc A composition and method for the regulation of cell proliferation and cell death
US6255473B1 (en) * 1997-08-29 2001-07-03 Duke University Presenilin-1 gene promoter
JP2003510282A (en) * 1999-09-25 2003-03-18 コーリー ファーマシューティカル ゲーエムベーハー Immunostimulatory nucleic acid
DE60043759D1 (en) * 1999-12-13 2010-03-11 Bioniche Life Sciences Inc Therapeutically useful synthetic oligonucleotides
US20020091095A1 (en) * 1999-12-13 2002-07-11 Phillips Nigel C. Modulation of Fas and FasL expression
US7125858B2 (en) * 1999-12-28 2006-10-24 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
DK1432450T3 (en) * 2001-10-03 2006-05-15 Bioniche Life Sciences Inc Therapeutically useful triethyleneglycol cholesteryl-oliconucleotider
CN101160399A (en) * 2002-04-22 2008-04-09 拜奥尼茨生命科学公司 Oligonucleotide compositions and their use for the modulation of immune responses

Also Published As

Publication number Publication date Type
CA2393808A1 (en) 2001-06-21 application
CN1433469A (en) 2003-07-30 application
ES2288883T3 (en) 2008-02-01 grant
DE60036019D1 (en) 2007-09-27 grant
DK1867718T3 (en) 2010-04-12 grant
CN100445380C (en) 2008-12-24 grant
EP1238070B1 (en) 2007-08-15 grant
EP1867718A3 (en) 2008-04-02 application
WO2001044465A3 (en) 2001-11-29 application
ES2340807T3 (en) 2010-06-09 grant
US20070213291A1 (en) 2007-09-13 application
DK1238070T3 (en) 2007-12-03 grant
CN101491536B (en) 2012-07-04 grant
EP1867718A2 (en) 2007-12-19 application
DE60036019T2 (en) 2008-05-29 grant
JP4772245B2 (en) 2011-09-14 grant
EP1238070A2 (en) 2002-09-11 application
WO2001044465A2 (en) 2001-06-21 application
EP1867718B1 (en) 2010-01-20 grant
JP2003517041A (en) 2003-05-20 application
US20010041681A1 (en) 2001-11-15 application
CN101491536A (en) 2009-07-29 application
US7157436B2 (en) 2007-01-02 grant

Similar Documents

Publication Publication Date Title
DE19907967B4 (en) Verschlußzentrierung
DE29902562U1 (en) Saugbagger
DE29901833U1 (en) Tumbler
DE29908299U1 (en) Ablenkschwelle
DE29910089U1 (en) Staubabsauggerät
DE29910061U1 (en) Wippsurfer
DE29903082U1 (en) Euro-Kellnerbörse
DE29905178U1 (en) Tiles
DE29907668U1 (en) Packerwalze
DE29909390U1 (en) Schraubkeil
DE19983890T1 (en) Ventiltaktgebungsjustiereinrichtung
DE29901180U1 (en) Panikhaken
DE29907700U1 (en) Sportrad
DE29902079U1 (en) Wickeltray
DE29907861U1 (en) Kreiselset
DE29910337U1 (en) Notausschütz
DE29900520U1 (en) Bierfaßkühler
DE29903114U1 (en) Studrails
DE29907509U1 (en) Balancierscheibe
DE29903759U1 (en) Baubeschlag
DE29904672U1 (en) Reerhitzbare Assiette
DE29902138U1 (en) Viehselbsttränkeinrichtung
DE29906312U1 (en) Laser-Three-way Linearitätsmeßvorrichtung
DE29904875U1 (en) Anreihklemme
DE29910201U1 (en) Kragarmregalvorrichtung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition